References
- . Noppakun N, Bancheun K, Chandraprasert S. Unusual locations of localized myxedema in Graves' disease. Report of three cases. Arch Dermatol. 1986;122(1):85–88
- . Schwartz KM, Fatourechi V, Ahmed DD, Pond GR. Dermopathy of Graves' disease (pretibial myxedema): long-term outcome. J Clin Endocrinol Metab. 2002;87(2):438–446
- . Kriss JP. Pathogenesis and treatment of pretibial myxedema. Endocrinol Metab Clin North Am. 1987;16(2):409–415
- . Fatourechi V, Pajouhi M, Fransway AF. Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases. Medicine (Baltimore). 1994;73(1):1–7
- . Fatourechi V, Bartley GB, Eghbali-Fatourechi GZ, Powell CC, Ahmed DD, Garrity JA. Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy. Thyroid. 2003;13(12):1141–1144
- . Fatourechi V, Ahmed DD, Schwartz KM. Thyroid acropachy: report of 40 patients treated at a single institution in a 26-year period. J Clin Endocrinol Metab. 2002;87(12):5435–5441
- . Seigel RS, Thrall JH, Sisson JC. 99mTc-pyrophosphate scan and radiographic correlation in thyroid acropachy: case report. J Nucl Med. 1976;17(9):791–793
- . Fatourechi V. Pretibial myxedema: pathophysiology and treatment options. Am J Clin Dermatol. 2005;6(5):295–309
- . Bull RH, Coburn PR, Mortimer PS. Pretibial myxoedema: a manifestation of lymphoedema? Lancet. 1993;341(8842):403–404
- . Daumerie C, Ludgate M, Costagliola S, Many MC. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. Eur J Endocrinol. 2002;146(1):35–38
- . Kiljanski J, Nebes V, Stachura I, Kennerdell JS, Wall JR. Should Graves' disease be considered a collagen disorder of the thyroid, skeletal muscle and connective tissue? Horm Metab Res. 1995;27(12):528–532
- . Davies TF. Trauma and pressure explain the clinical presentation of the Graves' disease triad. Thyroid. 2000;10(8):629–630
- . Singh SP, Ellyin F, Singh SK, Yoon B. Elephantiasic-like appearance of upper and lower extremities in Graves' dermopathy. Am J Med Sci. 1985;290(2):73–76
- . Rapoport B, Alsabeh R, Aftergood D, McLachlan SM. Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifest-ations of Graves' disease. Thyroid. 2000;10(8):685–692
- . Antonelli A, Navarranne A, Palla R, . Pretibial myxedema and high-dose intravenous immunoglobulin treatment. Thyroid. 1994;4(4):399–408
- . Kuzuya N, DeGroot LJ. Effect of plasmapheresis and steroid treatment on thyrotropin binding inhibitory immunoglobulins in a patient with exophthalmos and a patient with pretibial myxedema. J Endocrinol Invest. 1982;5(6):373–378
- . Derrick EK, Tanner B, Price ML. Successful surgical treatment of severe pretibial myxoedema. Br J Dermatol. 1995;133(2):317–318
- . Susser WS, Heermans AG, Chapman MS, Baughman RD. Elephantiasic pretibial myxedema: a novel treatment for an uncommon disorder. J Am Acad Dermatol. 2002;46(5):723–726